Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patients

Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patients

Background: Direct oral anticoagulants (DOACs) have been developed for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). We conducted a retrospective cohort study of patients with NVAF who were newly treated with DOACs in a real-world clinical setting. Methods: We retrospec...

Full description

Bibliographic Details
Main Authors: Masahiko Umei, MD, Mikio Kishi, MD, Takahiro Sato, MD, PhD, Akito Shindo, MD, Masayuki Toyoda, MD, Masaaki Yokoyama, MD, Masashiro Matsushita, MD, Satoshi Ohnishi, MD, Masao Yamasaki, MD, PhD
Format: Article
Language:English
Published: Wiley 2017-10-01
Series:Journal of Arrhythmia
Subjects:
Atrial fibrillation
Direct oral anticoagulants
Bleeding
Thromboembolism
Suboptimal dose
Online Access:http://www.sciencedirect.com/science/article/pii/S1880427617301035

Internet

http://www.sciencedirect.com/science/article/pii/S1880427617301035

Similar Items